色素性皮肤病患者的心理障碍:一项横断面研究
该前瞻性横断面研究于2015年6月至2017年12月在三级医院色素门诊纳入黄褐斑、白癜风和获得性皮肤黄斑色素沉着(ADMH)各100例皮损位于暴露部位的患者,评估焦虑、抑郁和躯体形式障碍的时点患病率。结果显示白癜风和ADMH患者的心理障碍患病率较高,且焦虑和抑郁患病率与疾病严重程度正相关。
要点
- 白癜风患者焦虑、抑郁和躯体形式障碍患病率分别为21%、27%和17.9%。
- ADMH患者焦虑、抑郁和躯体形式障碍患病率分别为18.7%、24.1%和14.3%。
- 黄褐斑患者焦虑、抑郁和躯体形式障碍患病率分别为11.6%、12.8%和8.1%。
核心结论
- 色素性疾病患者中焦虑、抑郁和躯体形式障碍的时点患病率较高,尤其是白癜风和ADMH。
- 焦虑和抑郁的患病率与疾病严重程度和活动性相关。
研究设计与样本
- 前瞻性横断面研究,于2015年6月至2017年12月在三级医院色素门诊进行。
- 纳入黄褐斑、ADMH和白癜风各100例,皮损位于暴露部位。
- 使用DLQI、PRIME-MD PHQ、PHQ-9、GAD-7和PHQ-15分别评估生活质量、精神共病、抑郁、广泛性焦虑障碍和躯体形式障碍。
主要发现
- 焦虑障碍患病率:黄褐斑11.6%,白癜风21%,ADMH 18.7%。
- 抑郁患病率:黄褐斑12.8%,白癜风27%,ADMH 24.1%。
- 躯体形式障碍患病率:白癜风17.9%,ADMH 14.3%,黄褐斑8.1%。
- 所有疾病中焦虑和抑郁的时点患病率与疾病严重程度呈正相关。
临床怎么用
- 对白癜风和ADMH患者应常规筛查焦虑、抑郁和躯体形式障碍。
- 疾病严重程度较高的色素性疾病患者心理障碍风险更高,需加强心理评估。
局限性
- 未来需要与一般健康人群比较以得出更肯定的结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Data on prevalence and factors influencing psychological burden in pigmentary disorders are scarce. OBJECTIVE: To determine the point prevalence of anxiety disorder, depression and somatoform disorder in patients with melasma, vitiligo and acquired dermal macular hyperpigmentation (ADMH). METHODS: A prospective cross-sectional study involving 100 patients each with melasma, ADMH and vitiligo with lesions on exposed body parts was conducted in the pigmentary clinic of a tertiary care referral hospital from June 2015 to December 2017. Dermatology life quality index, PRIME-MD Patient Health Questionnaire, Patient Health Questionnaire-9, Generalized Anxiety Disorder-7 and Patient Health Questionnaire-15 were used for assessment of quality of life, psychiatric comorbidities, depression, general anxiety disorder and somatoform disorders, respectively, and correlated with age, gender, occupation, marital status, severity and progression of the disease. RESULTS: The prevalence of anxiety disorder in patients with melasma, vitiligo and ADMH was 11.6%, 21% and 18.7%, respectively. Depression was seen in 12.8%, 27% and 24.1% patients with melasma, vitiligo and ADMH, respectively. Somatoform disorder was more common in vitiligo (17.9%) as compared to ADMH (14.3%) and melasma (8.1%). There were positive correlations between the severity of disease and the point prevalence of anxiety and depression in all disorders. CONCLUSION: A high point prevalence of anxiety, depression and somatoform disorders was observed with pigmentary diseases, especially vitiligo and ADMH. The prevalence of anxiety and depression correlated with the disease severity and activity. Future research involving comparison with the general healthy population is required for a more affirmative conclusion.
引用
- Dabas G, Vinay K, Parsad D, et al. Psychological disturbances in patients with pigmentary disorders: a cross-sectional study. J Eur Acad Dermatol Venereol. 2019. PMID: 31566833. doi:10.1111/jdv.15987
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。